Protagonist Therapeutics Inc buy JPMorgan Chase & Co.
Start price
07.11.25
/
50%
€69.00
Target price
07.11.26
€70.20
Performance (%)
22.46%
Price
10.04.26
€84.50
Summary
This prediction is currently active. The prediction currently has a performance of 22.46%. This prediction currently runs until 07.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -5.587% | -5.587% |
| iShares Core DAX® | 2,55 % | 0,56 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % |
| iShares S&P 500 | 1,93 % | -0,51 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $68.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€92.26
19.03.27
19.03.27
-3.98%
10.04.26
10.04.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.03.25
04.03.25
€54.07
04.03.26
04.03.26
66.34%
05.03.26
05.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.02.25
04.02.25
€51.09
04.02.26
04.02.26
40.59%
05.02.26
05.02.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
25.07.24
25.07.24
€44.18
25.07.25
25.07.25
-4.16%
26.07.25
26.07.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€84.50
28.02.24
28.02.24
€34.13
28.02.25
28.02.25
-
01.03.25
01.03.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€84.50
25.09.23
25.09.23
€32.11
25.09.24
25.09.24
-
26.09.24
26.09.24